美诺华：拟投资18.09亿元建设高端制剂全球化产业基地及研发项目

格隆汇07-01

美诺华(603538.SH)公告称，公司及子公司拟投资建设高端口服固体制剂和复杂注射剂全球化产业基地项目、高活性制剂及难溶性药物高端研发项目，总投资额为18.09亿元。其中，产业基地项目投资14.72亿元，研发项目投资3.37亿元。公司拟通过向特定对象发行A股股票募集资金投入，不足部分自筹解决。本次投资尚需股东会审议，不构成关联交易及重大资产重组。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2648514840?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-01 18:06","share_image_url":"https://static.laohu8.com/6b8fa6424aebe95f6781d04ef17a1852","id":"2648514840","market":"sh","top_or_hot":-1,"title":"美诺华：拟投资18.09亿元建设高端制剂全球化产业基地及研发项目","media":"格隆汇","content":"<html><body><p>美诺华(603538.SH)公告称，公司及子公司拟投资建设高端口服固体制剂和复杂注射剂全球化产业基地项目、高活性制剂及难溶性药物高端研发项目，总投资额为18.09亿元。其中，产业基地项目投资14.72亿元，研发项目投资3.37亿元。公司拟通过向特定对象发行A股股票募集资金投入，不足部分自筹解决。本次投资尚需股东会审议，不构成关联交易及重大资产重组。</p></body></html>","source":"live_gelonghui","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美诺华：拟投资18.09亿元建设高端制剂全球化产业基地及研发项目</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美诺华：拟投资18.09亿元建设高端制剂全球化产业基地及研发项目\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><p>美诺华(603538.SH)公告称，公司及子公司拟投资建设高端口服固体制剂和复杂注射剂全球化产业基地项目、高活性制剂及难溶性药物高端研发项目，总投资额为18.09亿元。其中，产业基地项目投资14.72亿元，研发项目投资3.37亿元。公司拟通过向特定对象发行A股股票募集资金投入，不足部分自筹解决。本次投资尚需股东会审议，不构成关联交易及重大资产重组。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.gelonghui.com/rss/live/live.xml\">格隆汇</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603538","symbol_name":"美诺华","start_time":0,"source_url":"https://www.gelonghui.com/rss/live/live.xml","article_id":"2648514840","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2648514840","pubTimestamp":1782900381,"columns":[],"sourceInfo":{"source_id":"live_gelonghui","name":"格隆汇"},"weMediaInfo":null,"summary":"美诺华(603538.SH)公告称，公司及子公司拟投资建设高端口服固体制剂和复杂注射剂全球化产业基地项目、高活性制剂及难溶性药物高端研发项目，总投资额为18.09亿元。其中，产业基地项目投资14.72","collect":0,"end_time":0,"defaultTopTitle":"gelonghui.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603538":"美诺华","BK0239":"医药制造"},"translate_title":"Minohua: Plans to invest 1.809 billion yuan to build a global industrial base and R&D project for high-end preparations","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603538":1.5},"content_text":"美诺华(603538.SH)公告称，公司及子公司拟投资建设高端口服固体制剂和复杂注射剂全球化产业基地项目、高活性制剂及难溶性药物高端研发项目，总投资额为18.09亿元。其中，产业基地项目投资14.72亿元，研发项目投资3.37亿元。公司拟通过向特定对象发行A股股票募集资金投入，不足部分自筹解决。本次投资尚需股东会审议，不构成关联交易及重大资产重组。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2648514840","isCrawlerRequest":true}